Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-03-23

    Virtual Booth

    An Enquiry

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    An Enquiry

    Menu

    Lubiprostone

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 868,128Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Lowey Notifies Payors of Amitiza Generics Class Action
    Lowey Notifies Payors of Amitiza Generics Class Action

    09 Mar 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/lowey-dannenberg-pc-announces-notice-of-class-action-if-you-paid-for-some-or-all-of-the-purchase-price-of-amitiza-and-or-generic-versions-of-amitiza-as-a-third-party-payor-302706947.html

    PR NEWSWIRE
    09 Mar 2026
    Share Share
    Towa Receives Manufacturing & Marketing Approval for Generic Drug
    Towa Receives Manufacturing & Marketing Approval for Generic Drug

    16 Feb 2026

    // PRESS RELEASE

    https://www.towayakuhin.co.jp/english/assets/release260216.pdf

    PRESS RELEASE
    16 Feb 2026
    Share Share
    Ascent Pharma`s Generics Lubiprostone Receives Approval in US
    Ascent Pharma`s Generics Lubiprostone Receives Approval in US

    02 Jan 2025

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218640

    FDA
    02 Jan 2025
    Share Share
    Takeda hit with another pay-for-delay lawsuit
    Takeda hit with another pay-for-delay lawsuit

    13 Apr 2023

    // Eric Sagonowsky FIERCE PHARMA

    https://www.fiercepharma.com/pharma/takeda-hit-another-pay-delay-lawsuit-time-colcrys

    Eric Sagonowsky FIERCE PHARMA
    13 Apr 2023
    Share Share
    Zydus Life gets USFDA nod for Lubiprostone capsules
    Zydus Life gets USFDA nod for Lubiprostone capsules

    25 Mar 2023

    // BUSINESS STANDARD

    https://www.business-standard.com/article/news-cm/zydus-life-gets-usfda-nod-for-lubiprostone-capsules-123032400856_1.html#:~:text=Zydus%20Lifesciences%20said%20that%20it,reference%20listed%20drug%2C%20Amitiza%20capsules.

    BUSINESS STANDARD
    25 Mar 2023
    Share Share
    Dr. Reddy's Generic Lubiprostone Receives Approval in the U.S.
    Dr. Reddy's Generic Lubiprostone Receives Approval in the U.S.

    08 Feb 2022

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206994

    FDA
    08 Feb 2022
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.